INmune Bio, Inc. (INMB)
1.385
-0.02
(-1.77%)
USD |
NASDAQ |
May 21, 13:06
INmune Bio Market Cap : 36.82M for May 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| PDS Biotechnology Corp. | 64.75M |
| Sangamo Therapeutics, Inc. | 64.21M |
| ACADIA Pharmaceuticals, Inc. | 3.617B |
| Alnylam Pharmaceuticals, Inc. | 39.97B |
| Amgen, Inc. | 180.69B |
Market Cap Related Metrics
| Price to Book Value | 1.876 |
| Price | 1.385 |
| Earnings Yield | -122.4% |